Psychological Resources Are Independently Associated with Markers of Inflammation in a Middle-Aged Community Sample

International Journal of Behavioral Medicine

Volumn 23, Issue 5, 2016, Pages 611-620

  Marteinsdottir, Ina ^a   Ernerudh, Jan ^a   Jonasson, Lena ^a   Kristenson, Margareta ^a   Garvin, Peter ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b The Research and Development Unit for Local Health Care   (Sweden)

Author keywords

Biomarker; Epidemiology; Inflammation; Positive psychology, self anchoring ladder; Psychoneuroimmunology

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6;

AGED; CARDIOVASCULAR DISEASE; COPING BEHAVIOR; CORONARY ARTERY DISEASE; DEPRESSION; FEMALE; HUMAN; INFLAMMATION; LIFESTYLE; MALE; MIDDLE AGED; PSYCHOLOGY; QUALITY OF LIFE; RISK FACTOR; SELF CONCEPT; SENSE OF COHERENCE;

ADAPTATION, PSYCHOLOGICAL; AGED; BIOMARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; DEPRESSION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIFE STYLE; MALE; MIDDLE AGED; QUALITY OF LIFE; RISK FACTORS; SELF CONCEPT; SENSE OF COHERENCE;

EID: 84961144789     PISSN: 10705503     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12529-016-9553-z     Document Type: Article

References (41)

1. Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. Jama. 2007;298:1685–7.
2. Albus C. Psychological and social factors in coronary heart disease. Ann Med. 2010;42:487–94. doi:10.3109/07853890.2010.515605.
3. Sher Y, Lolak S, Maldonado JR. The impact of depression in heart disease. Curr Psychiatry Rep. 2010;12:255–64. doi:10.1007/s11920-010-0116-8.
4. Hemingway H, Marmot M. Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ. 1999;318:1460–7.
5. Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364:953–62.
6. Appels A, Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur Heart J. 1988;9:758–64.
7. Everson SA, Goldberg DE, Kaplan GA, et al. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med. 1996;58:113–21.
8. Surtees PG, Wainwright NW, Luben R, Khaw KT, Day NE. Mastery, sense of coherence, and mortality: evidence of independent associations from the EPIC-Norfolk prospective cohort study. Health Psychol. 2006;25:102–10.
9. Giltay EJ, Kamphuis MH, Kalmijn S, Zitman FG, Kromhout D. Dispositional optimism and the risk of cardiovascular death: the Zutphen elderly study. Arch Intern Med. 2006;166:431–6. doi:10.1001/.431.
10. Kubzansky LD, Thurston RC. Emotional vitality and incident coronary heart disease: benefits of healthy psychological functioning. Arch Gen Psychiatry. 2007;64:1393–401. doi:10.1001/archpsyc.64.12.1393.
11. Shirai K, Iso H, Ohira T, et al. Perceived level of life enjoyment and risks of cardiovascular disease incidence and mortality: the Japan public health center-based study. Circulation. 2009;120:956–63. doi:10.1161/CIRCULATIONAHA.108.834176.
12. Lundgren O, Garvin P, Jonasson L, Andersson G, Kristenson M. Psychological resources are associated with reduced incidence of coronary heart disease. An 8-year follow-up of a community-based Swedish sample. Int J Behav Med. 2014. doi:10.1007/s12529-014-9387-5.
13. Ridker PM. Inflammation, C-reactive protein, and cardiovascular disease: moving past the marker versus mediator debate. Circ Res. 2014;114:594–5. doi:10.1161/CIRCRESAHA.114.303215.
14. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007;49:2129–38. doi:10.1016/j.jacc.2007.02.052.
15. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129–38. doi:10.1016/j.jacc.2009.09.009.
16. Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med. 2004;66:305–15.
17. Steptoe A, Dockray S, Wardle J. Positive affect and psychobiological processes relevant to health. J Pers. 2009;77:1747–76. doi:10.1111/j.1467-6494.2009.00599.x.
18. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171–86. doi:10.1097/PSY.0b013e3181907c1b.
19. Wium-Andersen MK, Orsted DD, Nielsen SF, Nordestgaard BG. Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiatry. 2013;70:176–84. doi:10.1001/2013.jamapsychiatry.102.
20. Gidron Y, Gilutz H, Berger R, Huleihel M. Molecular and cellular interface between behavior and acute coronary syndromes. Cardiovasc Res. 2002;56:15–21.
21. Sjogren E, Leanderson P, Kristenson M, Ernerudh J. Interleukin-6 levels in relation to psychosocial factors: studies on serum, saliva, and in vitro production by blood mononuclear cells. Brain Behav Immun. 2005.
22. Nabi H, Singh-Manoux A, Shipley M, Gimeno D, Marmot MG, Kivimaki M. Do psychological factors affect inflammation and incident coronary heart disease: the Whitehall II study. Arterioscler Thromb Vasc Biol. 2008;28:1398–406.
23. Garvin P, Nilsson L, Carstensen J, Jonasson L, Kristenson M. Plasma levels of matrix metalloproteinase-9 are independently associated with psychosocial factors in a middle-aged normal population. Psychosom Med. 2009;71:292–300.
24. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493–503.
25. Blankenberg S, Rupprecht HJ, Poirier O, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003;107:1579–85.
26. Dubois CM, Beach SR, Kashdan TB, et al. Positive psychological attributes and cardiac outcomes: associations, mechanisms, and interventions. Psychosomatics. 2012;53:303–18. doi:10.1016/j.psym.2012.04.004.
27. Hollman G, Kristenson M. The prevalence of the metabolic syndrome and its risk factors in a middle-aged Swedish population—mainly a function of overweight? Eur J Cardiovasc Nurs. 2007.
28. Khani BR, Ye W, Terry P, Wolk A. Reproducibility and validity of major dietary patterns among Swedish women assessed with a food-frequency questionnaire. J Nutr. 2004;134:1541–5.
29. Kallings LV, Leijon M, Hellenius ML, Stahle A. Physical activity on prescription in primary health care: a follow-up of physical activity level and quality of life. Scand J Med Sci Sports. 2007.
30. Pearlin LI, Schooler C. The structure of coping. J Health Soc Behav. 1978;19:19.
31. Rosenberg M. The association between self-esteem and anxiety. J Psychiatr Res. 1962;1:135–52.
32. Antonovsky A. Unraveling the mystery of health: how people manage stress and stay well. 1st ed. San Francisco: Jossey-Bass; 1987.
33. Cantril H. The pattern of human concerns. New Brunswick: Rutgers University Press; 1965.
34. The RL, Scale CES-D. A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.
35. Appels A, Hoppener P, Mulder P. A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol. 1987;17:15–24.
36. Gerlach RF, Demacq C, Jung K, Tanus-Santos JE. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Clin Biochem. 2007;40:119–23.
37. Steptoe A, O’Donnell K, Badrick E, Kumari M, Marmot M. Neuroendocrine and inflammatory factors associated with positive affect in healthy men and women: the Whitehall II study. Am J Epidemiol. 2008;167:96–102.
38. Ikeda A, Schwartz J, Peters JL, et al. Optimism in relation to inflammation and endothelial dysfunction in older men: the VA normative aging study. Psychosom Med. 2011;73:664–71. doi:10.1097/PSY.0b013e3182312497.
39. Roy B, Diez-Roux AV, Seeman T, Ranjit N, Shea S, Cushman M. Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA). Psychosom Med. 2010;72:134–40. doi:10.1097/PSY.0b013e3181cb981b.
40. Chapman BP, van Wijngaarden E, Seplaki CL, Talbot N, Duberstein P, Moynihan J. Openness and conscientiousness predict 34-week patterns of interleukin-6 in older persons. Brain Behav Immun. 2011;25:667–73.
41. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24–31.